摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-[2-(3,5-Dichloro-pyridin-4-yl)-1-oxoethyl]-10-methoxy-2,3,4,5-tetrahydro-1,6-benzodioxocine | 208043-46-3

中文名称
——
中文别名
——
英文名称
7-[2-(3,5-Dichloro-pyridin-4-yl)-1-oxoethyl]-10-methoxy-2,3,4,5-tetrahydro-1,6-benzodioxocine
英文别名
7-[2-(3,5-dichloro-pyridin-4-yl)-1-oxoethyl]-10-methoxy-2,3,4,5-tetrahydro-1,6-benzodioxocin;7-[2-(3,5-Dichloro-4-pyridyl)-1-oxoethyl]-10-methoxy-2,3,4,5-tetrahydro-1,6-benzodioxocine;7-[2-(3,5-dichloro-4-pyridyl)-1-oxoethyl]-10-methoxy-2,3,4,5-tetrahydro-1,6-benzodioxocin;2-(3,5-Dichloropyridin-4-yl)-1-(7-methoxy-2,3,4,5-tetrahydro-1,6-benzodioxocin-10-yl)ethanone
7-[2-(3,5-Dichloro-pyridin-4-yl)-1-oxoethyl]-10-methoxy-2,3,4,5-tetrahydro-1,6-benzodioxocine化学式
CAS
208043-46-3
化学式
C18H17Cl2NO4
mdl
——
分子量
382.243
InChiKey
GUOJACBTNONAOD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.8
  • 重原子数:
    25
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    57.6
  • 氢给体数:
    0
  • 氢受体数:
    5

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • DERIVATIVES OF BENZOFURAN OR BENZODIOXOLE
    申请人:——
    公开号:US20020128290A1
    公开(公告)日:2002-09-12
    An oxygen-containing heterocyclic compound represented by following Formula (I): 1 wherein R 1 and R 2 independently represent hydrogen, lower alkyl, cyano, —(CH 2 ) n —E 1 —CO—G 1 (wherein E 1 represents a bond, O, or NH; and G 1 represents hydrogen, substituted or unsubstituted lower alkyl, OR 6 , or NR 7 R 8 ; and n represents an integer of 0 to 4), or the like; R 1 and R 2 are combined to represent a saturated carbon ring together with a carbon atom adjacent thereto; or R 2 , and R 11 or R 13 described below are combined to form a single bond; R 3 represents hydrogen, phenyl, or halogen; R 4 represents hydroxy, lower alkoxy, or the like; A represents —C(R 9 )(R 10 )— or O; B represents O, NR 11 , —C(R 12 )(R 13 )—, or —C(R 14 )(R 15 )—C(R 16 )(R 17 )—; D represents (i) —C(R 18 )(R 19 )—X— (wherein X represents —C(R 21 )(R 22 )—, S, or NR 23 ), (ii) —C(R 19a )═Y— [Y represents —C(R 24 )—Z— (wherein Z represents CONH, CONHCH 2 , or a bond), or N], or (iii) a bond; and R 5 represents aryl, an aromatic heterocyclic group, cycloalkyl, pyridine-N-oxide, cyano, or lower alkoxycarbonyl; or pharmaceutically acceptable salts thereof.
    以下是由下式(I)表示的含氧杂环化合物: 其中R1和R2独立地表示氢、较低的烷基、氰基、—(CH2)n—E1—CO—G1(其中E1表示键、O或NH;G1表示氢、取代或未取代的较低烷基、OR6或NR7R8;n表示0到4的整数),或类似物;R1和R2结合表示与相邻碳原子一起形成饱和碳环;或R2,以及下文描述的R11或R13结合形成单键;R3表示氢、苯基或卤素;R4表示羟基、较低的烷氧基或类似物;A表示—C(R9)(R10)—或O;B表示O、NR11、—C(R12)(R13)—或—C(R14)(R15)—C(R16)(R17)—;D表示(i)—C(R18)(R19)—X—(其中X表示—C(R21)(R22)—、S或NR23)、(ii)—C(R19a)═Y—[Y表示—C(R24)—Z—(其中Z表示CONH、CONHCH2或键),或N],或(iii)键;R5表示芳基、芳香杂环基、环烷基、吡啶-N-氧化物、氰基或较低烷氧羰基;或其药学上可接受的盐。
  • OXYGENIC HETEROCYCLIC COMPOUNDS
    申请人:KYOWA HAKKO KOGYO KABUSHIKI KAISHA
    公开号:EP0943613A1
    公开(公告)日:1999-09-22
    Oxygen-containing heterocyclic compounds represented by following Formula (I): wherein n represents an integer of 1 to 4; R1, R2, R3 and R4 are the same or different and represent hydrogen, substituted or unsubstituted lower alkyl, or the like; R5 represents hydrogen or halogen; R6 represents hydroxy or substituted or unsubstituted lower alkoxy; D represents (1) -C(R8)(R9)-X- or (2) a bond; R7 represents (1) substituted or unsubstituted lower alkyl, substituted or unsubstituted cycloalkyl, polycycloalkyl, substituted or unsubstituted aryl, substituted or unsubstituted aralkyl, a substituted or unsubstituted aromatic heterocyclic group, a substituted or unsubstituted heterocyclic group, or pyridine-N-oxide, (2) -Y-ZR14, (3) -Y-Z-(CH2)m-N(R16a)R16b, or (4) -Y-CON(R17a)R17b, or pharmaceutically acceptable salts thereof.
    下式(I)所代表的含氧杂环化合物: 其中 n 代表 1 至 4 的整数;R1、R2、R3 和 R4 相同或不同,代表氢、取代或未取代的低级烷基或类似物; R5 代表氢或卤素;R6 代表羟基或取代或未取代的低级烷氧基;D 代表 (1) -C(R8)(R9)-X- 或 (2) 键;R7 代表 (1) 取代或未取代的低级烷基、取代或未取代的环烷基、多环烷基、取代或 未取代的芳基、取代或未取代的芳烷基、(2) -Y-ZR14, (3) -Y-Z-(CH2)m-N(R16a)R16b, 或 (4) -Y-CON(R17a)R17b, 或其药学上可接受的盐。
  • US6514996B2
    申请人:——
    公开号:US6514996B2
    公开(公告)日:2003-02-04
  • US6716987B1
    申请人:——
    公开号:US6716987B1
    公开(公告)日:2004-04-06
  • US7183293B2
    申请人:——
    公开号:US7183293B2
    公开(公告)日:2007-02-27
查看更多

同类化合物

胰岛素原(cattle),29-[N6-[[2-(甲磺酰)乙氧基]羰基]-L-赖氨酸]-59-[N6-[[2-(甲磺酰)乙氧基]羰基]-L-赖氨酸]-(9CI) 十氢-2,7-苯并二氧杂环癸烷-3,6-二酮 二环<3.3.0>-2-氧杂-5-(2-丙烯基)-1-辛烯 乙烯邻苯二甲酸酯 [(E,1R)-1-[(2R,4Z,7S,8R)-7-溴-8-乙基-3,6,7,8-四氢-2H-氧杂环辛三烯-2-基]己-3-烯-5-炔基]乙酸酯 [(2R,3S,4E,6R,7S)-6,7-二羟基-2-甲基-10-氧代-2,3,6,7,8,9-六氢氧杂环辛三烯-3-基] (E)-丁-2-烯酸酯 6,7-二氢-5aH-氧杂环丁烷并[3,2-d][1,3]苯并二氧戊环 5-氧杂-10-氮杂三环[5.3.1.03,8]十一碳-1(10),2,6,8-四烯 3-氧杂二环[3.3.1]壬-6-烯-9-酮 3,4,5,6-四氢-2,7-苯并二氧杂环癸烷e-1,8-二酮 10-(乙酰氧基)-4,5,6,7-四氢-2H-1-苯并氧杂环辛三烯-2,8(3H)-二酮 1-(2,3,4,5-四氢-1,6-苯并二噁辛英-8-基)丙烷-1-酮 1,2-环己烷二甲酸1-甲基-1,2-乙二基酯 (S)-5-烯丙基-2-氧杂双环[3.3.0]辛-8-烯 (7Z)-2-(3-溴丙-1,2-二烯基)-5-(1-溴丙基)-3,3a,5,6,9,9a-六氢-2H-呋喃并[3,2-b]氧杂环辛三烯 (7E)-4,7-二羟基-10-甲基-3,4,5,6,9,10-六氢氧杂环辛三烯-2-酮 (6Z)-10-甲基-3,4,5,8,9,10-六氢-2H-氧杂环辛三烯-2-酮 (5Z,8S)-3-氯-2-[(E)-戊-2-烯-4-炔基]-8-[(E)-丙-1-烯基]-3,4,7,8-四氢-2H-氧杂环辛三烯 (4Z)-3,6-二氢-2,7-苯并二氧杂环癸烷e-1,8-二酮 (4S,5Z,7S,8S,10R)-4,7,8-三羟基-10-甲基-3,4,7,8,9,10-六氢氧杂环辛三烯-2-酮 (4R,5R,6Z,8S,10R)-4,5,8-三羟基-10-甲基-3,4,5,8,9,10-六氢氧杂环辛三烯-2-酮 (2R,5Z)-8a-[(R)-1-溴丙基]-3a-氯-3,4,7,8-四氢-2a-[(Z)-2-戊烯-4-炔基]-2H-氧杂环辛三烯 1,3,3a,6a-tetrahydro-5-pentyl-4H-cyclopentafuran-4-one trans-1-oxacyclodec-7-ene-2-one 2-epi-herbarumin II (RS)-5-methoxy-2,3,5,6-tetrahydro-8H-benzo[1,4,7]trioxecin β-heptenolactone stagonolide-E fumaric acid butanediyl ester aspinolide A (3R,4R,9S,10R,Z)-4,9-dihydroxy-3-methyl-10-pentyl-3,4,7,8,9,10-hexahydro-2H-oxecin-2-one prelaureatin 8-acetyl-4,4-dimethyl-2,6-dioxo-9-(2-methylpropyl)-2,3,4,5,6,8-hexahydrooxocino[2,3-c]pyrrole 5,6-benzo-2,3-diethoxy-4-oxo-2-hepten-7-olide 3,4,5,6-tetrahydro-oxocin-2-one (Z)-3-butyl-5,6,7,8-tetrahydro-2H-oxocin-2-one presaccharothriolide X 1-{2-[4,5-dihydro-1H-2-benzoxocin-(6Z)-ylidenemethyl]-allyl}-piperidine (R,Z)-8-(methoxymethoxy)-2,2,6,9-tetramethyl-5,6-dihydro-2H-benzo[b]oxocine 5-hydroxy-7R,11-heliannan-10-one 8-methoxy-2,2,6,9-tetramethyl-2H-1-benzoxocin-3(4H)-one 8-methoxy-2,2,6,9-tetramethyl-3,4,5,6-tetrahydro-2H-1-benzoxocin-3-ol (4S,5Z,10R)-4-hydroxy-10-methyl-3,4,7,8,9,10-hexahydro-2H-oxecin-2-one (4R)-9,11-bis(benzyloxy)-4-methyl-4,5,6,7-tetrahydro-1H-benzo[d]-oxecine-2,8-dione ethyl (4Z)-4-methyl-7,8-dihydro-1,3,6-trioxocine-5-carboxylate 4-hydroxy-10-(2-hydroxyethyl)-1,2-dihydro-4,12a-methanooxocino[4,5-b][1,4]benzodioxin-5-one 4-hydroxy-9-(2-hydroxyethyl)-1,2-dihydro-4,12a-methanooxocino[4,5-b][1,4]benzodioxin-5-one (7R,9R,5E)-7-hydroxy-9-propylnon-5-en-9-olide (6S,7R,9R)-6,7-dihydroxy-9-propylnon-4-eno-9-lactone 7-[2-(3,5-Dichloro-N-oxo-pyridin-4-yl)-1-oxoethyl]-10-methoxy-2,3,4,5-tetrahydro-1,6-benzodioxocine